BVF INC/IL
Q4 2013 13F-HR Holdings
Net value change ($000)
—
New positions
24
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to previous filing: —
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| LGND | 138,136 | — |
| IRWD | 111,173 | — |
| ChemoCentryx, Inc. | 45,142 | — |
| ARRAY BIOPHARMA INC | 37,841 | — |
| ONCOMED PHARMACEUTICALS INC COM | 32,191 | — |
| TARGACEPT INC COM | 25,612 | — |
| RIGL | 22,638 | — |
| ONCOTHYREON INC | 15,843 | — |
| CYTK | 15,398 | — |
| QLT INC | 13,202 | — |
Top Reduces (Value $000, Stocks/ETFs)
| — |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|